The present invention relates to compounds of formula I and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors.
-
Page/Page column 14
(2008/06/13)
More Articles about upstream products of 868851-36-9